-
DERUFF-4
Symptomatic treatment off mild to moderately severe Alzheimer's dementia. This is only the preview. Please check here for the full indication. -
ERISK
Improvement of myotonic conditions caused by the following diseases: Neck-shoulder-arm syndrome, scapulohumeral periarthritis and low back pain. Spastic paralysis caused by the following diseases: Cerebrovascular… -
ESSEIL-10
Cilnidipin is indicated for the treatment of hypertension. This is only the preview. Please check here for the full indication. -
ESSEIL-5
Cilnidipin is indicated for the treatment of hypertension. This is only the preview. Please check here for the full indication. -
EVALDEZ
Relief of symptoms of dyspeptic syndrome: bloating, epigastric discomfort, heartburn, belching, nausea, vomiting. Treatment of acute and chronic schizophrenia. This is only the preview. Please… -
EZATUX
[pdf-embedder url="https://davipharm.info/wp-content/uploads/EZATUX_0090.T2.pdf"] -
FLUCOTED
FLUCOTED is indicated in adults for the treatment of: - Cryptococcal meningitis. - Coccidioidomycosis. - Mucosal candidiasis including oropharyngeal, oesophageal candidiasis, candiduria. - Vaginal candidiasis,… -
FORLEN
Linezolid is indicated in adult for treatment of the following infections caused by susceptible strains of the designated microorganisms: - Vancomycin-Resistant Enterococcus faecium infections, including… -
GAYAX
Amisulprid is indicated for the treatment of acute and chronic schizophrenic disorders in which positive symptoms (such as delusions, hallucinations and thought disorders) and/or negative… -
GAYAX-400
Amisulprid is indicated for the treatment of acute and chronic schizophrenic disorders in which positive symptoms (such as delusions, hallucinations and thought disorders) and/or negative… -
GIVET-10
Prophylaxis and chronic treatment of asthma in adults and pediatric patients 6 years and older, including prevention of daytime and nighttime asthma symptoms, treatment of… -
GLOCKNER-5
Symptomatic treatment of thyrotoxicosis (including Graves-Basedow’ disease). Treatment of hyperthyroidism in preparation for thyroidectomy until the basal metabolism rate return to normal to prevent possible… -
GON SA ATZETI
Therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due… -
GON SA EZETI-10
Primary Hypercholesterolaemia: Ezetimibe co-administered with an HMG-CoA reductase inhibitor (statin) is indicated as adjunctive therapy to diet for use in patients with primary (heterozygous familial…